Product Images Alogliptin And Metformin Hydrochloride

This appears to be a table or figure from a clinical trial comparing the effects of placebo, alogliptin, metformin, and a combination of alogliptin and metformin on the treatment of an undisclosed condition. The table presents mean baseline values and changes in values for three dosing regimens of the drugs in question, with statistical significance noted for the combination therapy. No additional information about the study or condition is available in the text provided.*

This is a medication that should not be accepted if the seal over the bottle is broken or missing and should be kept away from children. The usual dosage can be found in the package insert. Each film-coated tablet contains 17 mg of alogliptin benzoate equivalent to 12.5 mg of alogliptin and 500 mg metformin HCI. It should be stored at 25°C (77°F) and dispensed in a tightly closed container. Additionally, the medication comes with a medication guide and is distributed by Perrigo. The NDC number is 45802-169-72 and the product is Alogliptin and Metformin HCI Tablets, with a strength of 12.5mg/500mg. The bottle contains 60 tablets.*

This is a medication that contains alogliptin benzoate and metformin HCI in the form of film-coated tablets. Users are warned not to accept the drug if the seal over the bottle opening is broken or missing. The usual dosage instructions can be found in the package insert. It is important to store the medication at a temperature range between 15°-30°C (59°-86°F) to maintain effectiveness. The drug should be kept out of reach of children and dispensed in a tightly closed container along with a medication guide. The distribution is handled by Perrigo with an address located in Allegan, MI. The NDC number for this medication is 45802-211-72.*